Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Intravenous heroin addicts (IVHAs) have a high prevalence of Hepatitis C Virus (HCV) infection, exceeding 90%.
• While other hepatitis viruses (A, B, D, G) are less significant, active Hepatitis B can present similarly to chronic HCV.
• The clinical course for both HCV and active Hepatitis B can be long-term, spanning over three decades.

Purpose of the Study:

• To highlight the significant impact of HCV in IVHAs.
• To emphasize the importance of staging liver disease (active, cirrhosis, liver failure).
• To underscore the potential for antiviral therapy in the early, active stage of HCV.

Main Methods:

• Clinical observation and classification of patients based on disease stage.
• Monitoring of liver enzymes (ALT and AST) to identify active disease.
• Review of extra-hepatic manifestations associated with HCV.

Main Results:

• HCV is the predominant hepatitis virus among IVHAs.
• Elevated ALT and AST levels are indicative of the active, early stage of the disease.
• HCV presents with numerous extra-hepatic manifestations, suggesting a systemic 'HCV syndrome'.

Conclusions:

• HCV infection is a major health issue for IVHAs, often leading to chronic liver damage.
• Early-stage intervention with antiviral therapy offers the best chance for successful treatment.
• HCV should be recognized as a syndrome with widespread systemic effects beyond the liver.